These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 35033181)
21. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression. Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332 [TBL] [Abstract][Full Text] [Related]
22. Visualized Analyses of Investigations Upon Mesenchymal Stem/stromal Cell-based Cytotherapy and Underlying Mechanisms for COVID-19 Associated ARDS. Aitong W; Leisheng Z; Hao Y Curr Stem Cell Res Ther; 2022; 17(1):2-12. PubMed ID: 34254927 [TBL] [Abstract][Full Text] [Related]
23. Clinical progress in MSC-based therapies for the management of severe COVID-19. Rossello-Gelabert M; Gonzalez-Pujana A; Igartua M; Santos-Vizcaino E; Hernandez RM Cytokine Growth Factor Rev; 2022 Dec; 68():25-36. PubMed ID: 35843774 [TBL] [Abstract][Full Text] [Related]
24. The efficacy of mesenchymal stromal cell-derived therapies for acute respiratory distress syndrome-a meta-analysis of preclinical trials. Wang F; Fang B; Qiang X; Shao J; Zhou L Respir Res; 2020 Nov; 21(1):307. PubMed ID: 33218340 [TBL] [Abstract][Full Text] [Related]
25. A study on the role of apoptotic human umbilical cord mesenchymal stem cells in bleomycin-induced acute lung injury in rat models. Liu FB; Lin Q; Liu ZW Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):969-82. PubMed ID: 27010158 [TBL] [Abstract][Full Text] [Related]
26. Feasibility of Mesenchymal Stem Cell Therapy for COVID-19: A Mini Review. Li J; Wang X; Li N; Jiang Y; Huang H; Wang T; Lin Z; Xiong N Curr Gene Ther; 2020; 20(4):285-288. PubMed ID: 32867652 [TBL] [Abstract][Full Text] [Related]
27. Mesenchymal Stromal Cells Modulate Macrophages in Clinically Relevant Lung Injury Models by Extracellular Vesicle Mitochondrial Transfer. Morrison TJ; Jackson MV; Cunningham EK; Kissenpfennig A; McAuley DF; O'Kane CM; Krasnodembskaya AD Am J Respir Crit Care Med; 2017 Nov; 196(10):1275-1286. PubMed ID: 28598224 [TBL] [Abstract][Full Text] [Related]
28. Mast cells activated by SARS-CoV-2 release histamine which increases IL-1 levels causing cytokine storm and inflammatory reaction in COVID-19. Conti P; Caraffa A; Tetè G; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Di Emidio P; Ronconi G J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1629-1632. PubMed ID: 32945158 [TBL] [Abstract][Full Text] [Related]
29. May mesenchymal stem cell transplantation be a solution for COVID-19 induced cytokine storm? Sütlüoğlu H; Özdemir Ö World J Transplant; 2021 Aug; 11(8):344-355. PubMed ID: 34447671 [TBL] [Abstract][Full Text] [Related]
30. The immunological response among COVID-19 patients with acute respiratory distress syndrome. Almutairi AS; Abunurah H; Hadi Alanazi A; Alenazi F; Nagy H; Saad Almutairi N; Wells M; Alawam A; Alqahtani MM J Infect Public Health; 2021 Jul; 14(7):954-959. PubMed ID: 34130119 [TBL] [Abstract][Full Text] [Related]
31. Extracellular Vesicle Associated miRNAs Regulate Signaling Pathways Involved in COVID-19 Pneumonia and the Progression to Severe Acute Respiratory Corona Virus-2 Syndrome. Meidert AS; Hermann S; Brandes F; Kirchner B; Buschmann D; Billaud JN; Klein M; Lindemann A; Aue E; Schelling G; Pfaffl MW; Reithmair M Front Immunol; 2021; 12():784028. PubMed ID: 34956213 [TBL] [Abstract][Full Text] [Related]
32. The immune modulatory effects of umbilical cord-derived mesenchymal stromal cells in severe COVID-19 pneumonia. Ciccocioppo R; Gibellini D; Astori G; Bernardi M; Bozza A; Chieregato K; Elice F; Ugel S; Caligola S; De Sanctis F; Canè S; Fiore A; Trovato R; Vella A; Petrova V; Amodeo G; Santimaria M; Mazzariol A; Frulloni L; Ruggeri M; Polati E; Bronte V Stem Cell Res Ther; 2021 Jun; 12(1):316. PubMed ID: 34078447 [TBL] [Abstract][Full Text] [Related]
33. Current Status of Cell-Based Therapies for COVID-19: Evidence From Mesenchymal Stromal Cells in Sepsis and ARDS. Xu Z; Huang Y; Zhou J; Deng X; He W; Liu X; Li Y; Zhong N; Sang L Front Immunol; 2021; 12():738697. PubMed ID: 34659231 [TBL] [Abstract][Full Text] [Related]
34. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS. Lupu L; Palmer A; Huber-Lang M Front Immunol; 2020; 11():584514. PubMed ID: 33101314 [TBL] [Abstract][Full Text] [Related]
35. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the SARS-CoV-2 Cytokine Storm. Torabi-Rahvar M; Rezaei N Curr Pharm Des; 2021; 27(13):1549-1552. PubMed ID: 33238863 [TBL] [Abstract][Full Text] [Related]
36. The Immunomodulatory Role of Cell-Free Approaches in SARS-CoV-2-Induced Cytokine Storm-A Powerful Therapeutic Tool for COVID-19 Patients. Csobonyeiova M; Smolinska V; Harsanyi S; Ivantysyn M; Klein M Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371831 [TBL] [Abstract][Full Text] [Related]